Somatostatin‐Like Immunoreactivity in the Cerebrospinal Fluid of Aged Patients with Parkinson's Disease

E-ISSN： 1532-5415|38|1|19-24

ISSN： 0002-8614

Source： JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol.38, Iss.1, 1990-01, pp. : 19-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early‐stage Parkinson's disease

ANNALS OF NEUROLOGY, Vol. 78, Iss. 6, 2015-12 ,pp. : 1000-1004

John Wiley & Sons Inc

Access to resources Recommend Favorite

TREATMENT OF PARKINSON'S DISEASE IN THE AGED

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 4, Iss. 5, 1956-05 ,pp. : 491-497

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular Effects of Levodopa in Aged versus Younger Patients with Parkinson's Disease

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 24, Iss. 4, 1976-04 ,pp. : 185-188

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 936-944

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 282-288

John Wiley & Sons Inc

Access to resources Recommend Favorite